Kim, Mi-Yeon
Kim, Mi Jeong
Lee, Changyeob
Lee, Juwon
Kim, Sang Seong
Hong, Sungho
Kim, Hyoung Tae
Seo, Jinsoo http://orcid.org/0000-0001-6432-6964
Yoon, Ki-Jun http://orcid.org/0000-0003-2985-2541
Han, Sungho
Funding for this research was provided by:
National Research Foundation of Korea (2019R1C1C1006600, 2020M3A9E4039670, 2018M3C7A1056275)
Korea Health Industry Development Institute (HI18C1801, HI18C1801, HI18C1801)
Article History
Received: 15 September 2022
Revised: 9 July 2023
Accepted: 9 July 2023
First Online: 2 October 2023
Competing interests
: M.-Y.K. and S.H. are inventors of PCT/KR2017/013444 and its family patent applications regarding the use of trametinib for neurodegenerative disease. M.-Y.K., M.J.K., and S.H. are stockholders of Genuv Inc. The authors declare no competing interest.